放疗联合瘤内持续递送抗CD40与抗PDL1增强抗肿瘤疗效
本研究在4T1三阴性乳腺癌小鼠模型中,采用纳米流体药物洗脱种子(NDES)持续瘤内递送抗CD40和抗PDL1抗体,并与放疗联合。结果显示,相比腹腔全身给药,该联合策略增强局部和全身免疫应答,显著减轻肿瘤负荷和肝脏炎症,并增强远隔效应对肺转移的抑制作用。
要点
- NDES瘤内持续递送抗CD40/PDL1联合放疗增强局部和全身免疫应答。
- 联合治疗显著减轻肿瘤负荷和肝脏炎症,优于全身给药。
- 该策略增强远隔效应,抑制肺转移负荷。
核心结论
- 放疗联合NDES持续瘤内递送抗CD40和抗PDL1抗体具有更优疗效,有望提高治疗指数和临床反应。
研究设计与样本
- 研究在4T1小鼠晚期三阴性乳腺癌模型中,比较NDES瘤内递送与腹腔全身给药的疗效。
- 采用影像质谱流式和流式细胞术评估局部和全身免疫应答,并对肝和肺进行组织学分析。
主要发现
- RT联合NDES CD40/PDL1显示局部和全身免疫应答增加。
- 与全身治疗相比,RT联合NDES CD40/PDL1实现显著肿瘤负荷减轻和肝脏炎症缓解。
- 该治疗策略增强远隔效应,减轻肺转移负荷。
临床怎么用
- 该NDES瘤内持续递送平台联合放疗可能为改善免疫治疗疗效和降低毒性提供新途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Mounting evidence demonstrates that combining radiation therapy (RT) with immunotherapy can reduce tumor burden in a subset of patients. However, conventional systemic delivery of immunotherapeutics is often associated with significant adverse effects, which force treatment cessation. The aim of this study was to investigate a minimally invasive therapeutics delivery approach to improve clinical response while attenuating toxicity. METHODS AND MATERIALS: We used a nanofluidic drug-eluting seed (NDES) for sustained intratumoral delivery of combinational antibodies CD40 and PDL1. To enhance immune and tumor response, we combined the NDES intratumoral platform with RT to treat the 4T1 murine model of advanced triple negative breast cancer. We compared the efficacy of NDES against intraperitoneal administration, which mimics conventional systemic treatment. Tumor growth was recorded, and local and systemic immune responses were assessed via imaging mass cytometry and flow cytometry. Livers and lungs were histologically analyzed for evaluation of toxicity and metastasis, respectively. RESULTS: The combination of RT and sustained intratumoral immunotherapy delivery of CD40 and PDL1 via NDES (NDES CD40/PDL1) showed an increase in both local and systemic immune response. In combination with RT, NDES CD40/PDL1 achieved significant tumor burden reduction and liver inflammation mitigation compared with systemic treatment. Importantly, our treatment strategy boosted the abscopal effect toward attenuating lung metastatic burden. CONCLUSIONS: Overall, our study demonstrated superior efficacy of combination treatment with RT and sustained intratumoral immunotherapy via NDES, offering promise for improving therapeutic index and clinical response.
引用
- Liu HC, Viswanath DI, Pesaresi F, et al. Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1. Int J Radiat Oncol Biol Phys. 2020. PMID: 32768562. doi:10.1016/j.ijrobp.2020.07.2326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。